
1. j clin gastroenterol. 2008 sep;42 suppl 3 pt 1:s126-9. doi:
10.1097/mcg.0b013e31816fc2f6.

use vsl[sharp]3 treatment rotavirus diarrhea children:
preliminary results.

dubey ap(1), rajeshwari k, chakravarty a, famularo g.

author information: 
(1)department pediatrics, maulana azad medical college, new delhi, india.
apdubey52@rediffmail.com

we conducted double-blind randomized placebo-controlled study evaluate
efficacy tolerability vsl[sharp]3 (cd pharma india) treatment of
acute rotavirus diarrhea children. patients randomly assigned to
receive 4 days oral treatment vsl[sharp]3 probiotic mixture placebo in
addition usual care diarrhea.results: 230 rotavirus-positive acute 
diarrhea children, 224 children completed study, (113 drug group and
111 placebo group). recruitment day 1, significant
differences 2 groups terms frequency vomiting, mean loose
stool frequency, stool consistency, mean frequency oral rehydration salts 
(ors) intravenous fluids administered. day 2, lower mean stool frequency
and improved stool consistency noted drug group, achieved
statistical significance. also reflected lower volume ors
administration drug group. even day 3, mean loose stool frequency and
frequency ors use frequency intravenous fluid use significantly
lower drug group. differences frequency loose stools
persisted till 8 hours day 4. this, placebo group also showed
spontaneous improvement difference 2 groups terms the
overall stools frequency became comparable. however, overall ors requirement 
continued significantly lower drug group even day 4. overall 
recovery rates significantly better drug group compared placebo.
no side effects noted use probiotic mixture. use of
probiotic mixture vsl[sharp]3 acute rotavirus diarrhea resulted earlier
recovery reduced frequency ors administration reflecting decreased stool
volume losses diarrhea.

doi: 10.1097/mcg.0b013e31816fc2f6 
pmid: 18806703  [indexed medline]

